PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
04-Dec-2024 Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy Everest Medicines Limited
04-Dec-2024 Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001 Thermosome
03-Dec-2024 Multi-Center Superiority Clinical Trial, Supported by Terumo Blood and Cell Technologies, Aims to Significantly Reduce Complications From Acute Chest Syndrome in Adult Sickle Cell Disease Patients Terumo Blood and Cell Technologies
03-Dec-2024 Efficacy of Vyepti highlighted by new clinical trial results in severe migraine Lundbeck
29-Nov-2024 Richmond Pharmacology Announces Promotions of Dr Matej Goricar and Dr Amir Majid Richmond Pharmacology
29-Nov-2024 Clinical trial spots Preston man’s potentially cancerous polyp Panthera Biopartners
26-Nov-2024 Anocca Announces Submission of Clinical Trial Application for Multi-asset Trial VIDAR-1 in Advanced Pancreatic Cancer Anocca
25-Nov-2024 Innovative Trials celebrates initiative success with industry peers at 2024 PMEA Awards Innovative Trials
25-Nov-2024 iiCON supports new phase II trial of novel pneumococcal vaccine, PnuBioVax iiCON
21-Nov-2024 Panthera Biopartners now offers the broadest range of clinical trial therapy areas of any site management organisation in the UK Panthera Biopartners
20-Nov-2024 KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles KOELIS
20-Nov-2024 Lindus Health Rolls Out “All-in-One Infectious Disease CRO” Bespoke to Clinical Trials for Infectious Disease Interventions Lindus Health
19-Nov-2024 Modus Therapeutics Receives Approval to Initiate a Phase IIa Clinical Trial for Chronic Kidney Disease (CKD) Modus Therapeutics
19-Nov-2024 Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001 Thermosome
14-Nov-2024 Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer Coronado Research
13-Nov-2024 Microbiotica Announces First Patient Dosed in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients Microbiotica
13-Nov-2024 Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial with ORX750, a Novel Orexin Receptor 2 (OX2R) Agonist Nxera Pharma
12-Nov-2024 Gifthealth Announces Strategic Partnership with United Digestive Gifthealth
12-Nov-2024 French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance AdipoPharma
11-Nov-2024 AstraZeneca and Amgen’s Tezspire meets both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps AstraZeneca